DK264787A - Anvendelse af humant alfa-interferon til fremstilling af et pharmaceutisk praeparat - Google Patents

Anvendelse af humant alfa-interferon til fremstilling af et pharmaceutisk praeparat

Info

Publication number: DK264787A
Authority: DK; Denmark
Prior art keywords: preparation; humant; application; alfa interferon; interferon
Prior art date: 1986-05-27

Application number

DK264787A

Other languages

English (en)

Other versions

DK264787D0 (da

Inventor

Daniel Jay Tanner

Edwin Arnold Peets

Kenneth Albert Smiles

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-05-27

Filing date

1987-05-25

Publication date

1987-11-28

1987-05-25 Application filed by Schering Corp filed Critical Schering Corp

1987-05-25 Publication of DK264787D0 publication Critical patent/DK264787D0/da

1987-11-28 Publication of DK264787A publication Critical patent/DK264787A/da

Links

102000014150 Interferons Human genes 0.000 title 1
108010050904 Interferons Proteins 0.000 title 1
229940079322 interferon Drugs 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
206010004146 Basal cell carcinoma Diseases 0.000 abstract 1
108010078049 Interferon alpha-2 Proteins 0.000 abstract 1
108010047761 Interferon-alpha Proteins 0.000 abstract 1
102000006992 Interferon-alpha Human genes 0.000 abstract 1
229960003507 interferon alfa-2b Drugs 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
MIXCUJKCXRNYFM-UHFFFAOYSA-M sodium;diiodomethanesulfonate;n-propyl-n-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide Chemical compound [Na+].[O-]S(=O)(=O)C(I)I.C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl MIXCUJKCXRNYFM-UHFFFAOYSA-M 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DK264787A 1986-05-27 1987-05-25 Anvendelse af humant alfa-interferon til fremstilling af et pharmaceutisk praeparat DK264787A (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US86664486A	1986-05-27	1986-05-27

Publications (2)

Publication Number	Publication Date
DK264787D0 DK264787D0 (da)	1987-05-25
DK264787A true DK264787A (da)	1987-11-28

Family

ID=25348060

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK264787A DK264787A (da)	1986-05-27	1987-05-25	Anvendelse af humant alfa-interferon til fremstilling af et pharmaceutisk praeparat

Country Status (13)

Country	Link
EP (1)	EP0248583B1 (da)
JP (1)	JPS62289526A (da)
KR (1)	KR870010871A (da)
AT (1)	ATE100717T1 (da)
AU (1)	AU601741B2 (da)
CA (1)	CA1295243C (da)
DE (1)	DE3788899T2 (da)
DK (1)	DK264787A (da)
ES (1)	ES2061496T3 (da)
IE (1)	IE62318B1 (da)
IL (1)	IL82654A0 (da)
PH (1)	PH26198A (da)
ZA (1)	ZA873743B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5028422A (en) *	1986-05-27	1991-07-02	Schering Corporation	Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
EP0278715A3 (en) *	1987-02-09	1989-03-08	Schering Corporation	Use of human gamma interferon for treatment of basal cell carcinoma
US5256410A (en) *	1988-12-01	1993-10-26	Schering Corporation	Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
MY107071A (en) *	1988-12-01	1995-09-30	Schering Corp	Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
PT99837A (pt) *	1990-12-21	1992-12-31	Schering Corp	Processo para a preparacao de composicoes farmaceuticas contendo interferao alfa e metodo para administracao de interferao alfa por inalacao oral para tratar asma e doencas pulmonares proliferativas nao malignas
EP3600379B1 (en)	2017-03-31	2022-12-21	Accanis Biotech F&E GmbH & Co KG	Prevention and treatment of non-melanoma skin cancer (nmsc)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3278234D1 (en) *	1981-10-13	1988-04-21	Exovir Inc	Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
US5098703A (en) *	1982-01-15	1992-03-24	Cetus Corporation	Interferon-alpha 76
AU1152983A (en) *	1982-01-15	1983-07-28	Cetus Corporation	Interferon alpha 74
AU1153083A (en) *	1982-01-15	1983-07-28	Cetus Corporation	Interferon-alpha 54
US4822605A (en) *	1986-02-18	1989-04-18	Exovir, Inc.	Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
US4853218A (en) *	1987-02-24	1989-08-01	Schering Corporation	Zinc-protamine-alpha interferon complex

1987
- 1987-05-25 AU AU73366/87A patent/AU601741B2/en not_active Ceased
- 1987-05-25 CA CA000537837A patent/CA1295243C/en not_active Expired - Lifetime
- 1987-05-25 DK DK264787A patent/DK264787A/da not_active Application Discontinuation
- 1987-05-25 PH PH35292A patent/PH26198A/en unknown
- 1987-05-25 IE IE135887A patent/IE62318B1/en not_active IP Right Cessation
- 1987-05-25 ZA ZA873743A patent/ZA873743B/xx unknown
- 1987-05-26 ES ES87304642T patent/ES2061496T3/es not_active Expired - Lifetime
- 1987-05-26 KR KR870005198A patent/KR870010871A/ko not_active Ceased
- 1987-05-26 IL IL82654A patent/IL82654A0/xx not_active IP Right Cessation
- 1987-05-26 EP EP87304642A patent/EP0248583B1/en not_active Expired - Lifetime
- 1987-05-26 DE DE87304642T patent/DE3788899T2/de not_active Expired - Fee Related
- 1987-05-26 AT AT87304642T patent/ATE100717T1/de not_active IP Right Cessation
- 1987-05-26 JP JP62129563A patent/JPS62289526A/ja active Pending

Also Published As

Publication number	Publication date
EP0248583A2 (en)	1987-12-09
ZA873743B (en)	1987-11-25
JPS62289526A (ja)	1987-12-16
ATE100717T1 (de)	1994-02-15
AU601741B2 (en)	1990-09-20
CA1295243C (en)	1992-02-04
DE3788899D1 (de)	1994-03-10
ES2061496T3 (es)	1994-12-16
PH26198A (en)	1992-03-18
IL82654A0 (en)	1987-11-30
EP0248583B1 (en)	1994-01-26
DK264787D0 (da)	1987-05-25
AU7336687A (en)	1987-12-03
EP0248583A3 (en)	1989-10-18
DE3788899T2 (de)	1994-05-05
IE62318B1 (en)	1995-01-25
KR870010871A (ko)	1987-12-18
IE871358L (en)	1987-11-27

Legal Events

Date	Code	Title	Description
1997-01-13	AHB	Application shelved due to non-payment

Publication	Publication Date	Title
FI874706L (fi)	1988-04-28	Menetelmä glykosyloimattoman yhdistelmäinterferoni- :n stabiilien, farmaseuttisten koostumusten valmistamiseksi
DK203787D0 (da)	1987-04-22	Praeparat til nasal administrering
IT1208343B (it)	1989-06-12	Siringa dentaria per iniezioni intralegamentarie
ATE73321T1 (de)	1992-03-15	Zusammensetzung mit verzoegerter abgabe.
DE3575072D1 (de)	1990-02-08	Pharmazeutische zusammensetzungen von mikrobenerzeugtem interleukin-2.
IT8419681A0 (it)	1984-02-17	Composizioni farmaceutiche per il trattamento del diabete e di malattie e disfunzioni epatiche.
DK0553294T3 (da)	1999-08-23	Fremstillingen af sammensætninger til behandlingen af celleproliferationssygdomme
DK264787D0 (da)	1987-05-25	Anvendelse af humant alfa-interferon til fremstilling af et pharmaceutisk praeparat
DK0643973T3 (da)	2003-09-08	Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi
ATE67783T1 (de)	1991-10-15	Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
FI863078A0 (fi)	1986-07-28	Kontinuerligt frigoerande peptidkompositioner.
DK328088D0 (da)	1988-06-15	Farmaceutisk komposition til behandling af tumorer
ES2115582T3 (es)	1998-07-01	Preparacion y aplicaciones de interferon-gamma.
GR3006999T3 (da)	1993-06-30
DK103891A (da)	1991-05-31	Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon
IT1095388B (it)	1985-08-10	Composizione farmaceutica per la somministrazione di pancreatina
DE3869789D1 (de)	1992-05-14	Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.
DK469487A (da)	1988-03-11	Laegemiddel til behandling af fedme
IT8622051A0 (it)	1986-10-17	Composizioni farmaceutiche adattivita' cicatrizzante.
NO882983L (no)	1988-09-06	Oral doseringsform for interferon for menneskelig bruk.
DK0381584T3 (da)	1994-02-14	Anvendelse af visse gamma-interferoner til behandling af ovariecancer